摘要 |
The present invention relates to triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione; metalloproteinase inhibitors of the formula wherein X, A, Y, B, G, W, and R<1 >are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
|